Smith & Nephew Plc , Europe’s largest maker of knee and hip replacements, said it’s not in talks that may lead to a takeover or merger after the Daily Telegraph reported the company was about to start informal negotiations with Biomet Inc.
Novartis AG ’s fourth-quarter profit fell 6 percent as sales of influenza vaccine declined following the end of the flu pandemic and the company wrote down the value of a cancer drug. The stock fell the most in almost seven months.
AstraZeneca Plc’s $1.26 billion purchase of Ardea Biosciences Inc., its biggest acquisition in five years, may be the first in a series of deals for the company as it tries to counter looming generic competition.
AstraZeneca Plc, the U.K.’s second- biggest drugmaker, raised its full-year profit forecast for a third time, even after second-quarter earnings fell due to increased generic competition and government price cuts.
AstraZeneca Plc, the U.K.’s second- biggest drugmaker, rose the most more than two months in London trading after winning U.S. approval to sell the blood-thinner Brilinta, a rival to the world’s second-best selling drug.